Search research articles
Contact Us
Filters
Showing results (171-180 of 176) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 176 results.
Australian and New Zealand Journal of Medicine
|
February 1, 1986
A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemia
J F Bishop, D E Joshua, R M Lowenthal, et al.
Thrombosis and Haemostasis
|
January 31, 2002
Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study
B H Chong, A S Gallus, J F Cade, et al.
Cancer Treatment Reports
|
December 1, 1987
Oral idarubicin as single-agent treatment of acute nonlymphocytic leukemia in poor-risk patients
R M Lowenthal, C N Chesterman, J D Griffiths, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
January 6, 2016
Histological Features and Tissue Microarray Taxonomy of Nigerian Breast Cancer Reveal Predominance of the High-Grade Triple-Negative Phenotype
N A Titloye, A Foster, G O Omoniyi-Esan, et al.
Leukemia & Lymphoma
|
September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)
R M Lowenthal, K F Bradstock, J P Matthews, et al.
Leukemia
|
October 26, 2022
Central nervous system involvement in childhood acute lymphoblastic leukemia is linked to upregulation of cholesterol biosynthetic pathways
A Cousins, O Olivares, E Markert, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 176) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 176 results.
Australian and New Zealand Journal of Medicine
|
February 1, 1986
A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemia
J F Bishop, D E Joshua, R M Lowenthal, et al.
Thrombosis and Haemostasis
|
January 31, 2002
Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study
B H Chong, A S Gallus, J F Cade, et al.
Cancer Treatment Reports
|
December 1, 1987
Oral idarubicin as single-agent treatment of acute nonlymphocytic leukemia in poor-risk patients
R M Lowenthal, C N Chesterman, J D Griffiths, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
January 6, 2016
Histological Features and Tissue Microarray Taxonomy of Nigerian Breast Cancer Reveal Predominance of the High-Grade Triple-Negative Phenotype
N A Titloye, A Foster, G O Omoniyi-Esan, et al.
Leukemia & Lymphoma
|
September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)
R M Lowenthal, K F Bradstock, J P Matthews, et al.
Leukemia
|
October 26, 2022
Central nervous system involvement in childhood acute lymphoblastic leukemia is linked to upregulation of cholesterol biosynthetic pathways
A Cousins, O Olivares, E Markert, et al.
Page
of 18